{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:24:33Z","timestamp":1759937073009,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.cellimm.2006.07.003","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T17:06:30Z","timestamp":1156525590000},"page":"107-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Intracellular delivery of purine nucleoside phosphorylase (PNP) fused to protein transduction domain corrects PNP deficiency in vitro"],"prefix":"10.1016","volume":"240","author":[{"given":"Ana","family":"Toro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron","family":"Ackerley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyal","family":"Grunebaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2006.07.003_bib1","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1081\/NCN-200027647","article-title":"Novel mutations and hot-spots in patients with purine nucleoside phosphorylase deficiency","volume":"23","author":"Grunebaum","year":"2004","journal-title":"Nucleos. Nucleot. Nucl. Acids"},{"key":"10.1016\/j.cellimm.2006.07.003_bib2","first-page":"143","article-title":"Immunodeficiency caused by purine nucleoside phosphorylase deficiency","volume":"vol. 20","author":"Cohen","year":"2000"},{"key":"10.1016\/j.cellimm.2006.07.003_bib3","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1084\/jem.191.12.2197","article-title":"Mitochondrial basis for immune deficiency. Evidence from purine nucleoside phosphorylase-deficient mice","volume":"191","author":"Arpaia","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2006.07.003_bib4","first-page":"45","article-title":"Purine nucleoside phosphorylase deficiency","volume":"3","author":"Markert","year":"1991","journal-title":"Immunodefic. Rev."},{"key":"10.1016\/j.cellimm.2006.07.003_bib5","first-page":"291","article-title":"Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy","volume":"35","author":"Hershfield","year":"1998","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.cellimm.2006.07.003_bib6","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM198010233031705","article-title":"Purine nucleoside phosphorylase deficiency: improved metabolic and immunologic function with erythrocyte transfusions","volume":"303","author":"Rich","year":"1980","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellimm.2006.07.003_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF00917017","article-title":"Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients","volume":"7","author":"Markert","year":"1987","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cellimm.2006.07.003_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2005.07.006","article-title":"Long-term efficacy of enzyme replacement therapy for Adenosine deaminase (ADA)-deficient Severe Combined Immunodeficiency (SCID)","volume":"117","author":"Chan","year":"2005","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cellimm.2006.07.003_bib9","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1002\/eji.200526248","article-title":"Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol\u2013adenosine deaminase-treated patients","volume":"35","author":"Malacarne","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2006.07.003_bib10","doi-asserted-by":"crossref","first-page":"32114","DOI":"10.1074\/jbc.M005153200","article-title":"The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities","volume":"275","author":"Blackburn","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2006.07.003_bib11","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar1861","article-title":"Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene) glycol (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase","volume":"8","author":"Ganson","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cellimm.2006.07.003_bib12","first-page":"23","article-title":"Treatment of genotype 1b HCV-related chronic hepatitis: efficacy and toxicity of three different interferon alfa-2b\/ribavirin combined regimens in naive patients","volume":"28","author":"Scotto","year":"2005","journal-title":"New Microbiol."},{"key":"10.1016\/j.cellimm.2006.07.003_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mcn.2004.03.005","article-title":"Delivery of bioactive molecules into the cell: the Trojan horse approach","volume":"27","author":"Dietz","year":"2004","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.cellimm.2006.07.003_bib14","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2006.07.003_bib15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nm996","article-title":"Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis","volume":"10","author":"Wadia","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2006.07.003_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/meth.2001.1186","article-title":"TAT-mediated protein transduction into mammalian cells","volume":"24","author":"Becker-Hapak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.cellimm.2006.07.003_bib17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1034\/j.1399-0004.2001.590608.x","article-title":"Two novel mutations in a purine nucleoside phosphorylase (PNP)-deficient patient","volume":"59","author":"Dalal","year":"2001","journal-title":"Clin. Genet."},{"key":"10.1016\/j.cellimm.2006.07.003_bib18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1203\/01.PDR.0000111286.23110.F8","article-title":"Purine nucleoside phosphorylase deficiency associated with a dysplastic marrow morphology","volume":"55","author":"Dror","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.cellimm.2006.07.003_bib19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1083\/jcb.57.2.551","article-title":"A technique for ultracryotomy of cell suspensions and tissues","volume":"57","author":"Tokuyasu","year":"1971","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cellimm.2006.07.003_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2249.2002.02000.x","article-title":"The role of anti-endothelial cell antibodies in Kawasaki disease \u2013 in vitro and in vivo studies","volume":"130","author":"Grunebaum","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellimm.2006.07.003_bib21","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1021\/bi002443l","article-title":"Ability if the Tat basic domain and VP22 to mediate cell binding but not membrane translocation of the diphteria toxin A-fragment","volume":"40","author":"O Falnes","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.cellimm.2006.07.003_bib22","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S1525-0016(03)00130-8","article-title":"A novel TAT-mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta","volume":"7","author":"Del Gaizo","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cellimm.2006.07.003_bib23","doi-asserted-by":"crossref","first-page":"10041","DOI":"10.1158\/0008-5472.CAN-05-1383","article-title":"Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma","volume":"65","author":"Batchu","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2006.07.003_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/adc.79.1.48","article-title":"Immunoglobulin replacement treatment by rapid subcutaneous infusion","volume":"79","author":"Gaspar","year":"1998","journal-title":"Arch Dis. Child"},{"key":"10.1016\/j.cellimm.2006.07.003_bib25","first-page":"328","article-title":"Characteristics of HIV-Tat protein transduction domain","volume":"42","author":"Yoon","year":"2004","journal-title":"J. Microbiol."},{"key":"10.1016\/j.cellimm.2006.07.003_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.virol.2005.02.024","article-title":"Intracellular route and biological activity of exogenously delivered Rep proteins from the adeno-associated virus type 2","volume":"335","author":"Awedikian","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.cellimm.2006.07.003_bib27","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1083\/jcb.91.3.837","article-title":"Purine nucleoside phosphorylase is associated with centrioles and basal bodies","volume":"91","author":"Oliver","year":"1981","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cellimm.2006.07.003_bib28","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1091\/mbc.e03-12-0921","article-title":"HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses","volume":"15","author":"Vendeville","year":"2004","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.cellimm.2006.07.003_bib29","doi-asserted-by":"crossref","first-page":"38376","DOI":"10.1074\/jbc.M506630200","article-title":"The C terminus of HIV-1 Tat modulates the extent of CD178-mediated apoptosis of T cells","volume":"280","author":"Campbell","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2006.07.003_bib30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.addr.2004.12.001","article-title":"Tat peptide-mediated cellular delivery: back to basics","volume":"57","author":"Brooks","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cellimm.2006.07.003_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0736-5748(00)00084-8","article-title":"Involvement of astrocytes in purine-mediated reparative processes in the brain","volume":"19","author":"Ciccarelli","year":"2001","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.cellimm.2006.07.003_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/glia.10055","article-title":"Mechanisms of apoptosis induced by purine nucleosides in astrocytes","volume":"38","author":"Di Iorio","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.cellimm.2006.07.003_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2516.2005.01170.x","article-title":"Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience","volume":"12","author":"Carcao","year":"2006","journal-title":"Haemophilia"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874906001201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874906001201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:40:26Z","timestamp":1757803226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874906001201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0008874906001201"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2006.07.003","relation":{},"ISSN":["0008-8749"],"issn-type":[{"type":"print","value":"0008-8749"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracellular delivery of purine nucleoside phosphorylase (PNP) fused to protein transduction domain corrects PNP deficiency in vitro","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2006.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}